Though it has been reported that NRF2 activation may reduce cholesterol injury by regulating the lipid homeostasis, how the hyperactivation of this transcription factor in NAFLD leads to HCC needs to be further clarified. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.